taflotan sine 15 mikrogramm/ml augentropfen im einzeldosisbehältnis
taflotan sine 15 mikrogramm/ml augentropfen im einzeldosisbehältnis
taptiqom 0.015/5 mg/ml col·liri 30 monodosis 0.3 ml
cosopt sine 20 mg/ml + 5 mg/ml augentropfen, lösung
saflutan 15mcg/ml eye drops, solution
lumigan
abbvie limited - bimatoprost 0.3 mg/ml; - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
lumigan pf
abbvie limited - bimatoprost 0.3 mg/ml; - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.
ilevro
novartis new zealand ltd - nepafenac 3 mg/ml - eye drops, suspension - 0.3 % - active: nepafenac 3 mg/ml excipient: benzalkonium chloride boric acid carbomer 974 carmellose sodium disodium edetate guar gum hydrochloric acid propylene glycol purified water sodium chloride sodium hydroxide - ilevro is indicated for the prevention and treatment of postoperative pain and inflammation associated with cataract surgery.
ilevro nepafenac 0.3% eye drops, suspension, bottle
novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.
ilevro nepafenac 0.3% eye drops, suspension, oval bottle
novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.